Back to Search
ELIZABETH DEES, MD
MD
Medical Oncology Physician
NPI: 1578631644IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 1993
Research & Publications (20)
A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors.
PMID 18327587·Cancer Chemother Pharmacol·2008
3-trial
Targeting the ubiquitin-proteasome pathway in breast cancer therapy.
PMID 16556079·Future Oncol·2006
6-review
Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer.
PMID 15185007·Cancer Immunol Immunother·2004
8-other
A phase I and pharmacologic study of pyrazoloacridine and cisplatin in patients with advanced cancer.
PMID 12795532·Invest New Drugs·2003
3-trial
A phase I and pharmacokinetic study of short infusions of UCN-01 in patients with refractory solid tumors.
PMID 15701854·Clin Cancer Res·2005
3-trial
A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumors.
PMID 11051234·Clin Cancer Res·2000
3-trial
A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer.
PMID 10923100·Cancer Invest·2000
8-other
Quantifying the recruitment challenges with couple-based interventions for cancer: applications to early-stage breast cancer.
PMID 19061201·Psychooncology·2009
8-other
Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans.
PMID 19114462·Drug Metab Dispos·2009
8-other
Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.
PMID 19255312·J Clin Oncol·2009
3-trial
Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.
PMID 18449006·J Thorac Oncol·2008
3-trial
Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ.
PMID 18650159·Clin Breast Cancer·2008
8-other
CMF1-Rb interaction promotes myogenesis in avian skeletal myoblasts.
PMID 18425850·Dev Dyn·2008
7-preclinical
The influence of CYP3A5 expression on the extent of hepatic CYP3A inhibition is substrate-dependent: an in vitro-in vivo evaluation.
PMID 17954524·Drug Metab Dispos·2008
7-preclinical
The interaction of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms and quality of life.
PMID 18213677·Psychooncology·2008
8-other
Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
PMID 18270338·J Natl Cancer Inst·2008
8-other
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
PMID 17438091·Clin Cancer Res·2007
8-other
Women's interest in gene expression analysis for breast cancer recurrence risk.
PMID 17925559·J Clin Oncol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 MANNING DR
CHAPEL HILL, NC 27599 - Phone
- (919) 966-4996
Quick Facts
- NPI
- 1578631644
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile